CVS Health Corp

CVS Health Corp

CVS

Market Cap$84.72B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
CVS Health CorpCVS Health Corp163.97%7%0.20.8

Earnings Call Q1 2025

May 1, 2025 - AI Summary

Solid Financial Performance and Increased Guidance: CVS Health reported Q1 2025 adjusted EPS of $2.25 and adjusted operating income of $4.6 billion, with revenues of nearly $95 billion, reflecting a 7% year-over-year increase. The company raised its full-year adjusted EPS guidance to a range of $6.00 to $6.20, up from $5.75 to $6.00, which indicates confidence in continued strong performance across its segments.
Challenges in Medicare Advantage and Individual Exchange Business: While the overall Medicare business showed improvement, CVS plans to exit its individual exchange business by 2026 due to ongoing losses, which are expected to be between $350 million and $400 million for 2025. Despite this exit, CVS aims to maintain service for affected members throughout 2025.
Enhancing Access to Life-Changing Medications: CVS announced a partnership with Novo Nordisk to increase access to Wegovy (a GLP-1 medication) at a more affordable price, which aligns with CVS's history of driving down drug costs through preferred formularies. This may broaden the potential coverage for weight loss treatments, providing an opportunity to enhance competitive positioning in the healthcare market.

Exclusive for Stockcircle Pro members

Sign upSign Up
$77.00

Target Price by Analysts

27.3% upsideCVS Health Target Price DetailsTarget Price
$81.74

Current Fair Value

35.1% upside

Undervalued by 35.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$84.72 Billion
Enterprise Value$139.35 Billion
Dividend Yield$2.66 (3.97192772883381%)
Earnings per Share$3.66
Beta0.6
Outstanding Shares1,261,000,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio15.99
PEG26.73
Price to Sales0.2
Price to Book Ratio0.99
Enterprise Value to Revenue0.37
Enterprise Value to EBIT15.16
Enterprise Value to Net Income26
Total Debt to Enterprise0.46
Debt to Equity0.84

Revenue Sources

No data

Insider Trades

ESG Score

No data

About CVS Health Corp

CEO: Larry Merlo